Mark Stanley

1.8k total citations
15 papers, 882 citations indexed

About

Mark Stanley is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mark Stanley has authored 15 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Mark Stanley's work include Chemical Synthesis and Analysis (3 papers), Melanoma and MAPK Pathways (3 papers) and Vanadium and Halogenation Chemistry (2 papers). Mark Stanley is often cited by papers focused on Chemical Synthesis and Analysis (3 papers), Melanoma and MAPK Pathways (3 papers) and Vanadium and Halogenation Chemistry (2 papers). Mark Stanley collaborates with scholars based in United States, France and Poland. Mark Stanley's co-authors include A. Richard Chamberlin, Michael W. Anderson, Richard J. Bridges, Carl W. Cotman, John P. Burnier, David Y. Jackson, Jeffrey Tom, Clifford Quan, James A. Wells and Robert S. McDowell and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Endocrinology.

In The Last Decade

Mark Stanley

15 papers receiving 839 citations

Peers

Countries citing papers authored by Mark Stanley

Since Specialization

Citations

This map shows the geographic impact of Mark Stanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stanley more than expected).

Fields of papers citing papers by Mark Stanley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Stanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stanley. The network helps show where Mark Stanley may publish in the future.

Co-authorship network of co-authors of Mark Stanley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Stanley. A scholar is included among the top collaborators of Mark Stanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Stanley. Mark Stanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors 2014 ·Bioorganic & Medicinal Chemistry Letters ·Lan Wang, Mark Stanley, Jason Boggs, Terry D. Crawford, Brandon Bravo, Anthony M. Giannetti, Seth F. Harris, Steven Magnuson, Jim Nonomiya, (unknown), Ping Wu, Weilan Ye, Stephen E. Gould, Lesley Murray, Chudi Ndubaku, Huifen Chen	19
2	The Crystal Structure of the Catalytic Domain of the NF-κB Inducing Kinase Reveals a Narrow but Flexible Active Site 2012 ·Structure ·(unknown), Krista K. Bowman, Jianwen A. Feng, Terry D. Crawford, Christine Everett, Yvonne Franke, Angela Oh, Mark Stanley, Steven T. Staben, Melissa A. Starovasnik, Heidi J.A. Wallweber, Jian Wu, Lawren C. Wu, Adam R. Johnson, S.G. Hymowitz	50
3	A new regulatory switch in a JAK protein kinase 2010 ·Proteins Structure Function and Bioinformatics ·Vickie Tsui, Paul Gibbons, Mark Ultsch, Kyle Mortara, Christine Chang, Wade Blair, Rebecca Pulk, Mark Stanley, Melissa A. Starovasnik, David J. Williams, (unknown), Philip M. Leonard, Steven Magnuson, Jun Liang, Charles Eigenbrot	20
4	N -Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: Structure–activity relationship of the benzoyl moiety 2004 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Burdick, James C. Marsters, (unknown), Mark Stanley, Maureen H. Beresini, Kevin Clark, Robert S. McDowell, Thomas R. Gadek	10
5	N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure–activity relationship 2003 ·Bioorganic & Medicinal Chemistry Letters ·Daniel J. Burdick, (unknown), Kenneth J. Weese, Mark Stanley, Maureen H. Beresini, Kevin Clark, Robert S. McDowell, James C. Marsters, Thomas R. Gadek	15
6	In vitro characterization of four novel classes of growth hormone-releasing peptide. 1995 ·Endocrinology ·Kathleen A. Elias, Gladys S. Ingle, John P. Burnier, R. Glenn Hammonds, Robert S. McDowell, Thomas E. Rawson, T. C. Somers, Mark Stanley, (unknown)	59
7	Growth hormone secretagogues: characterization, efficacy, and minimal bioactive conformation. 1995 ·Proceedings of the National Academy of Sciences ·Robert S. McDowell, Kathleen A. Elias, Mark Stanley, Daniel J. Burdick, John P. Burnier, (unknown), Wayne J. Fairbrother, R. Glenn Hammonds, Gladys S. Ingle, Neil E. Jacobsen	60
8	Benzodiazepine peptidomimetic inhibitors of farnesyltransferase 1994 ·Bioorganic & Medicinal Chemistry ·James C. Marsters, Robert S. McDowell, Mark E. Reynolds, D. A. OARE, Todd C. Somers, Mark Stanley, Thomas E. Rawson, (unknown), Daniel J. Burdick, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	40
9	Separation and Degradative Action of Polygalacturonase Isozymes Produced by Colletotrichum musae 1994 ·Journal of Phytopathology ·Mark Stanley, (unknown)	5
10	A Designed Peptide Ligase for Total Synthesis of Ribonuclease A with Unnatural Catalytic Residues 1994 ·Science ·David Y. Jackson, John P. Burnier, Clifford Quan, Mark Stanley, Jeffrey Tom, James A. Wells	230
11	Conformationally restricted inhibitors of the high affinity -glutamate transporter 1993 ·Bioorganic & Medicinal Chemistry Letters ·Richard J. Bridges, Frank Lovering, John M. Humphrey, Mark Stanley, (unknown), (unknown), A. Richard Chamberlin	53
12	Orthogonally protected N3-(carboxymethyl)-L-2,3-diaminopropanoic acids and O-(carboxymethyl)-L-serines for solid-phase peptide synthesis 1992 ·The Journal of Organic Chemistry ·Mark Stanley	29
13	Conformationally defined neurotransmitter analogs. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer 1991 ·Journal of Medicinal Chemistry ·Richard J. Bridges, Mark Stanley, Michael W. Anderson, Carl W. Cotman, A. Richard Chamberlin	286
14	Chlorination of α,β-unsaturated ketones and esters in the presence of acid scavengers 1991 ·Journal of the Chemical Society Perkin Transactions 2 ·Victor L. Heasley, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Terry Y. Shibuya, Mark Stanley, (unknown), Dale F. Shellhamer, G. E. HEASLEY	5
15	ChemInform Abstract: Effect of N‐Bromosuccinimide (NBS) and Other N‐Brominating Agents on the Bromination of α,β‐Unsaturated Ketones in Methanol. 1988 ·ChemInform ·Victor L. Heasley, (unknown), David K. Luttrull, (unknown), (unknown), (unknown), (unknown), (unknown), Terry Y. Shibuya, Mark Stanley, Dale F. Shellhamer, G. E. HEASLEY	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact